Skip to content
Recall Observatory FDA recall evidence

Drug product

Loxapine Capsules, USP 50 mg, Rx Only, 100-count bottles, NDC 0378-7050-01

D-0825-2018

April 24, 2018

Class II

Product summary

Firm
Mylan Pharmaceuticals Inc.
Event
Event 79955
Status
Terminated
Classification
Class II
Quantity
11,650 bottles
Official record key
drug-enforcement:D-0825-2018

Official wording

Reason: CGMP Deviations

Code information: NDC 0378-7050-01 Lot Numbers: 3079386, Exp. 10/31/18 3079387, Exp. 10/31/18 3079388, Exp. 10/31/18 3083762, Exp. 3/31/19 3083763, Exp. 3/31/19 3083764, Exp. 3/31/19 3083765, Exp. 3/31/19 3083766, Exp. 3/31/19 3083767, Exp. 3/31/19

Distribution pattern: Product was distributed throughout the United States, including Puerto Rico.

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations